HEAD-Study Optimizing the Treatment of Children With BECTS

NCT00471744 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped low patient number after 2 years recruiting

Conditions

Epilepsy, Rolandic

Interventions

DRUG: Treatment with levetiracetam or sulthiame over a six-month period.

Sponsor

Ludwig-Maximilians - University of Munich